WallStreetZenWallStreetZen

NASDAQ: ATAI
Atai Life Sciences Nv Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ATAI past revenue growth

How has ATAI's revenue growth performed historically?
Company
34.76%
Industry
148.97%
Market
17.57%
ATAI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ATAI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ATAI's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ATAI earnings and revenue history

Current Revenue
$314.0k
Current Earnings
-$40.2M
Current Profit Margin
-12,810.2%

ATAI Return on Equity

Current Company
-16.8%
Current Industry
-63.5%
Current Market
188%
ATAI's Return on Equity (-16.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ATAI announces earnings.

ATAI Return on Assets

Current Company
-14.2%
Current Industry
2.9%
ATAI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ATAI Return on Capital Employed

Current Company
-13.37%
Current Industry
19.5%
ATAI has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ATAI vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ATAI$314.00k-$35.85M-$40.22M-87.59%N/A
LXEO$0.00-$64.35M-$66.39M-100.00%N/A
PGEN$6.23M-$89.23M-$95.90M-47.16%N/A
RVNC$234.04M-$290.64M-$323.99M+128.84%N/A
AVXL$0.00-$43.04M-$43.16MN/AN/A
View Top Biotech Stocks

ATAI earnings dates

Next earnings date
May 7, 2024

Atai Life Sciences Nv Earnings & Revenue FAQ

What were ATAI's earnings last quarter?

On Invalid Date, Atai Life Sciences Nv (NASDAQ: ATAI) reported Q4 2023 earnings per share (EPS) of -$0.11, up 62.07% year over year. Total Atai Life Sciences Nv earnings for the quarter were -$18.29 million. In the same quarter last year, Atai Life Sciences Nv's earnings per share (EPS) was -$0.29.

If you're new to stock investing, here's how to buy Atai Life Sciences Nv stock.

What was ATAI's earnings growth in the past year?

As of Q2 2024, Atai Life Sciences Nv's earnings has grown year over year. Atai Life Sciences Nv's earnings in the past year totalled -$40.22 million.

What is ATAI's earnings date?

Atai Life Sciences Nv's earnings date is Invalid Date. Add ATAI to your watchlist to be reminded of ATAI's next earnings announcement.

What was ATAI's revenue last quarter?

On Invalid Date, Atai Life Sciences Nv (NASDAQ: ATAI) reported Q4 2023 revenue of $18.00 thousand up 52.63% year over year. In the same quarter last year, Atai Life Sciences Nv's revenue was $38.00 thousand.

What was ATAI's revenue growth in the past year?

As of Q2 2024, Atai Life Sciences Nv's revenue has grown 34.76% year over year. This is 114.21 percentage points lower than the US Biotechnology industry revenue growth rate of 148.97%. Atai Life Sciences Nv's revenue in the past year totalled $314.00 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.